Primary Treatment Trial

Salvage Treatment Trial

Patients (N)

12

12

Age

Median (yrs):

73

55

Range (yrs):

64 - 86

44 - 65

Gleason Score*

6

1 (8%)

3+4

9 (75%)

4 (33%)

4+3

1 (8%)

4 (33%)

8

2 (17%)

1 (8%)

9

2 (17%)

Tumor Category^†

T1

4 (33%)

T2

8 (67%)

9 (75%)

T3

3 (25%)

Initial PSA^‡

Median (ng/ml)

5.9

0.6

Range (ng/ml)

1.4 - 15.5

0.2 – 1.8

ADT

2 (17%)

N/A**

Treatment Arm

Standard

8 (67%)

6 (50%)

Experimental

4 (33%)

6 (50%)